Sign in to view content

Visual Acuity Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion in Routine Clinical Practice

Yasha S Modi, MD

Video
Published 2019

Related

Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Annual Meeting Talks
2024
Etiologic Profiling and Visual Outcomes of Dense Vitreous Hemorrhage Among Non-diabetics Treated With Pars Plana Vitrectomy
Narciso F. Atienza, MD, MBA, FASRS, FPCS, FPAO.
Annual Meeting Talks
2020
An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017

Category: Retinal Vascular Disease

See more